
Leukemias and lymphomas are estimated to contribute up to 7% of all new malignant cases in the United States.[1]

Your AI-Trained Oncology Knowledge Connection!


Leukemias and lymphomas are estimated to contribute up to 7% of all new malignant cases in the United States.[1]

The availability of a wide variety of treatments for multiple myeloma allows healthcare providers to tailor treatments to individual patient needs, and has enabled prolonged survival of patients with the disease.

Published: May 9th 2012 | Updated:

Published: April 19th 2011 | Updated: